When should the evaluation of erectile function be done before radical prostatectomy?

2019 ◽  
Vol 86 (3) ◽  
pp. 148-151
Author(s):  
Ali Yıldız ◽  
Kaan Karamık ◽  
Yasin Aktaş ◽  
Hakan Anıl ◽  
Ekrem İslamoğlu ◽  
...  

The aim of this study is to assess the erectile function of patients before and after transrectal ultrasound prostate biopsy comparatively in order to determine the appropriate time to evaluate erectile function before radical prostatectomy. A total of 44 patients underwent transrectal ultrasound biopsy. We used the International Index of Erectile Function-5 questionnaire to assess all the patients. In total, 44 volunteered patients were included in this study. All patients were evaluated with the International Index of Erectile Function-5 questionnaire before the biopsy and at 4 weeks after the transrectal ultrasound biopsy. A total of 50% of patients were potent before the biopsy was done. A month after the biopsies, erectile dysfunction was reported by 29 of 44 patients (66%) as mild in 10 (22.7%), as mild-moderate in 14 (31.8%), as moderate in 4 (9.1%), and severe in 1 (2.3%). The differences were statistically significant in the first month of the biopsy ( p < 0.05). The effect of prostate biopsy upon the erectile function is non-negligible. However, this situation is temporary and transient. Therefore, it is recommended that the International Index of Erectile Function-5 questionnaire is to be administered prior to prostate biopsy rather than before surgical treatment.

2013 ◽  
Vol 20 (2) ◽  
Author(s):  
Wibisono Wibisono ◽  
Doddy Musbadianto Soebadi ◽  
Sabilal Alif ◽  
Widodo Pudjirahardjo

Objective: To evaluate erectile function before and after transrectal ultrasound (TRUS) guided prostate biopsy using International Index of Erectile Function-5 (IIEF-5) and Erection Hardness Score (EHS) instrument. Material & Method: We conducted a study on 17 BPH LUTS patients who underwent TRUS guided prostate biopsy from January to April 2011 in Urological Minimal Invasive Installation (IIU) Dr. Soetomo Hospital. Out of 17 patients, three patients had mild ED, while 14 other patients had normal erectile function before the procedure. After TRUS guided prostate biopsy, we performed erectile function assessment using the IIEF-5 and EHS at weeks I, II, and IV. Results: Pathological examination of all specimens from prostate biopsy results revealed BPH. There were 2 patients with hematuria and 1 patient with rectal bleeding shortly after the biopsy, which resolved spontaneously less than 24 hours. Based on the IIEF-5 there were 4 patients (23,5%) with decreased erectile function in the evaluation of first week after prostate biopsy, and it reduced to 2 patients (11,7%) whose erectile function was still decreasing in the evaluation week II, while in fourth week evaluation there was 1 patient (5,9%) with decreased erectile function. Based on EHS data obtained, there were 5 patients (29,4%) with decreased scores in evaluations week II, and in the evaluation of week IV there were no patients having erectile function problems compared with EHS data before prostate biopsy. Conclusion: TRUS guided prostate biopsy can have temporary effect on erectile function.Keywords: Erectile dysfunction, prostate biopsy, international index of erectile function-5, erection hardness score.


2013 ◽  
Vol 85 (3) ◽  
pp. 130 ◽  
Author(s):  
Pietro Pepe ◽  
Francesco Pietropaolo ◽  
Giuseppe Dibenedetto ◽  
Francesco Aragona

Introduction: Erectile dysfunction (ED) incidence following repeat saturation prostate biopsy (SPBx) was evaluated. Materials and methods: From January 2011 to June 2012 295 patients underwent repeat transperineal SPBx (median 28 cores) under sedation. The indications for biopsy were: abnormal DRE, PSA &gt; 10 ng/mL or included between 4.1-10 with free/total PSA &lt; 25%. All patients were prospectively evaluated with the 5-item version of the International Index of Erectile Function (IIEF-5) at baseline and 1, 3 and 6 months from SPBx. Results: 100/200 men with benign histology and normal sexual activity completed the study; median IIEF-5 score before and after SPBx was equal to 18.3 (baseline) vs 17.8 (1 month later) vs 18 (3 months later) vs 18.1 (6 months later) (p &gt; 0.05); in detail, 1 month from biopsy 5 (5%) men referred a mild ED that disappeared at 3 and 6 months evaluation. Conclusions: Repeat transperineal SPBx under sedation did not significantly worsened erectile function; the minimal risk of temporary post-biopsy ED could be previously discussed (not emphasised) with potent patients.


2020 ◽  
pp. 631-650
Author(s):  
Suzanne Biers ◽  
Noel Armenakas ◽  
Alastair Lamb ◽  
Stephen Mark ◽  
John Reynard ◽  
...  

This chapter begins by covering the physiology of erections and ejaculation. It provides ways of evaluating erectile dysfunction and then surgical interventions, including vascular surgery and penile prosthesis. Finally, surgical treatment for Peyronie’s disease is covered.


F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 1923 ◽  
Author(s):  
Gideon Blecher ◽  
Khaled Almekaty ◽  
Odunayo Kalejaiye ◽  
Suks Minhas

In men undergoing radical treatment for prostate cancer, erectile function is one of the most important health-related quality-of-life outcomes influencing patient choice in treatment. Penile rehabilitation has emerged as a therapeutic measure to prevent erectile dysfunction and expedite return of erectile function after radical prostatectomy. Penile rehabilitation involves a program designed to increase the likelihood of return to baseline-level erectile function, as opposed to treatment, which implies the therapeutic treatment of symptoms, a key component of post–radical prostatectomy management. Several pathological theories form the basis for rehabilitation, and a plethora of treatments are currently in widespread use. However, whilst there is some evidence supporting the concept of penile rehabilitation from animal studies, randomised controlled trials are contradictory in outcomes. Similarly, urological guidelines are conflicted in terms of recommendations. Furthermore, it is clear that in spite of the lack of evidence for the role of penile rehabilitation, many urologists continue to employ some form of rehabilitation in their patients after radical prostatectomy. This is a significant burden to health resources in public-funded health economies, and no effective cost-benefit analysis has been undertaken to support this practice. Thus, further research is warranted to provide both scientific and clinical evidence for this contemporary practice and the development of preventative strategies in treating erectile dysfunction after radical prostatectomy.


2004 ◽  
Vol 171 (4S) ◽  
pp. 374-374
Author(s):  
Jang H. Kim ◽  
Yong Tae Kim ◽  
Brandon S. Minnery ◽  
Nelson E. Bennett ◽  
Darren Wolfe ◽  
...  

2017 ◽  
Vol 16 (5) ◽  
pp. e2199-e2200
Author(s):  
S. Aykan ◽  
E. Ates ◽  
O. Kose ◽  
H. Gulmez ◽  
M. Yilmaz ◽  
...  

2002 ◽  
Vol 167 (3) ◽  
pp. 1371-1375 ◽  
Author(s):  
JOHN P. MULHALL ◽  
RON SLOVICK ◽  
JAMES HOTALING ◽  
NADID AVIV ◽  
ROLANDO VALENZUELA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document